NASDAQ$BTTC

Black Titan Corp · Q4 2024 earnings

Q4 2024 earnings · Reported Apr 4, 2025 (last year) · After market close · Investor relations

Apr 4Dec 31, 2024

Total Revenue

$0.00

Previous: $0.00

EPS

-$0.86

Previous: -$0.05-1628.2%

Capital Expenditures

$0.00

Previous: -$2K+100.0%

Free Cash Flow

-$506K

Previous: -$2.25M+77.5%

Net Income

-$790K

Previous: -$1.97M+59.9%

Operating Income

-$666K

Previous: -$1.93M+65.5%

Gross Profit

$0.00

Previous: -$3K+100.0%

Cash & Equivalents

$2.83M

Previous: $6.77M-58.2%

Total Assets

$2.92M

Previous: $8.09M-63.9%

Titan Pharmaceuticals · Revenue · Quarterly

Q4 2024

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation